Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00120302Phase 4Completed
A Phase 4 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Novartis. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00120302.